Literature DB >> 22402315

Prostate cancer stem cell biology.

C Yu1, Z Yao, Y Jiang, E T Keller.   

Abstract

The cancer stem cell (CSC) model provides insights into pathophysiology of cancers and their therapeutic response. The CSC model has been both controversial, yet provides a foundation to explore cancer biology. In this review, we provide an overview of CSC concepts, biology and potential therapeutic avenues. We then focus on prostate CSC including 1) their purported origin as either basal-derived or luminal-derived cells; 2) markers used for prostate CSC identification; 3) alterations of signaling pathways in prostate CSCs; 4) involvement of prostate CSCs in metastasis of PCa; and 5) microRNA-mediated regulation of prostate CSCs. Although definitive evidence for the identification and characterization of prostate CSCs still remains unclear, future directions pursuing therapeutic targets of CSCs may provide novel insights for the treatment of PCa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402315      PMCID: PMC3332041     

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  120 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

4.  Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

Authors:  M L Guzman; S J Neering; D Upchurch; B Grimes; D S Howard; D A Rizzieri; S M Luger; C T Jordan
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

5.  Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer.

Authors:  Colby L Eaton; Marc Colombel; Gabri van der Pluijm; Marco Cecchini; Antoinette Wetterwald; Jenny Lippitt; Ishtiaq Rehman; Freddie Hamdy; George Thalman
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement.

Authors:  H F English; R J Santen; J T Isaacs
Journal:  Prostate       Date:  1987       Impact factor: 4.104

8.  In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.

Authors:  Natalia Guzmán-Ramírez; Maureen Völler; Antoinette Wetterwald; Markus Germann; Neil A Cross; Cyrill A Rentsch; Jack Schalken; George N Thalmann; Marco G Cecchini
Journal:  Prostate       Date:  2009-11-01       Impact factor: 4.104

9.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

Authors:  Gillian Farnie; Robert B Clarke; Katherine Spence; Natasha Pinnock; Keith Brennan; Neil G Anderson; Nigel J Bundred
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

10.  ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.

Authors:  Ting Li; Yun Su; Yuping Mei; Qixin Leng; Bingjie Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

View more
  14 in total

Review 1.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

Review 2.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 3.  Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.

Authors:  Bin Bao; Aamir Ahmad; Asfar S Azmi; Shadan Ali; Fazlul H Sarkar
Journal:  Curr Protoc Pharmacol       Date:  2013-06

4.  Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells.

Authors:  Lile He; Ananthan Sadagopan; Yida Zhang; Tao Ma; Gianpietro Dotti; Yufeng Wang; Hui Zheng; Xin Gao; Dian Wang; Albert B DeLeo; Song Fan; Ruochuan Sun; Ling Yu; Liyuan Zhang; Gongxian Wang; Soldano Ferrone; Xinhui Wang
Journal:  Mol Cancer Ther       Date:  2021-03       Impact factor: 6.261

5.  Evaluation of the effect of hyperthermia and electron radiation on prostate cancer stem cells.

Authors:  Zhila Rajaee; Samideh Khoei; Seied Rabi Mahdavi; Marzieh Ebrahimi; Sakine Shirvalilou; Alireza Mahdavian
Journal:  Radiat Environ Biophys       Date:  2018-02-17       Impact factor: 1.925

Review 6.  Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.

Authors:  Maurizio Romano; Francesco De Francesco; Giuseppe Pirozzi; Enrico Gringeri; Riccardo Boetto; Marina Di Domenico; Barbara Zavan; Giuseppe A Ferraro; Umberto Cillo
Journal:  Oncoscience       Date:  2015-05-15

7.  Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.

Authors:  Roberto Portillo-Lara; Mario Moisés Alvarez
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 8.  Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients.

Authors:  Engin Ulukaya; Didem Karakas; Konstantinos Dimas
Journal:  Medicina (Kaunas)       Date:  2021-06-19       Impact factor: 2.430

9.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

Review 10.  Cancer stem cells in prostate cancer.

Authors:  Felix Moltzahn; George N Thalmann
Journal:  Transl Androl Urol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.